The study was powered to detect overall objective response rate ( ORR ) in the glembatumumab vedotin arm between @ % ( null ) and @ % ( alternative hypothesis ) with preplanned investigation of activity by gpNMB distribution and/or intensity ( Stratum @ to Stratum @ ) .